抗中性粒细胞胞质抗体相关血管炎的皮肤表现
这项横断面研究基于全球130个中心1184例ANCA相关血管炎(AAV)患者,描述皮肤表现及其与系统性血管炎表现的关系。皮肤表现在GPA、MPA和EGPA中均常见,以瘀点/紫癜最常见;有皮肤病变者(尤其GPA、EGPA、抗PR3阳性或ANCA阴性者)更常出现严重系统性表现。
要点
- AAV各亚型皮肤表现常见:GPA 34%、MPA 28%、EGPA 47%。
- 瘀点/紫癜是最常见皮肤表现(15%),瘙痒、荨麻疹和斑丘疹在EGPA更常见。
- 皮肤活检使用不足但诊断效力高;有皮肤病变者严重系统表现更多。
核心结论
- 皮肤表现在AAV中常见且多样,并与GPA、EGPA、胞质型/抗PR3 ANCA阳性或ANCA阴性患者的疾病严重程度相关。
- 皮肤检查在AAV评估和管理中具有潜在的诊断和预后重要性。
研究设计与样本
- 横断面研究,利用大型国际协作收集的血管炎患者综合临床数据,识别并比较AAV的皮肤表现。
- 共纳入来自全球130个中心的1184例AAV患者。
主要发现
- 皮肤表现在GPA中为223/656(34%),MPA中为85/302(28%),EGPA中为106/226(47%)。
- AAV所有类型中最常见的皮肤表现是瘀点/紫癜,见于181例患者(15%)。
- 瘙痒、荨麻疹和斑丘疹等过敏性及非特异性表现更多见于EGPA,与其他亚型比较均P < 0.01。
- 皮肤活检执行率为22–44%,但在68–94%的患者中对AAV诊断有效。
- 与无皮肤表现者相比,有皮肤病变者更常出现严重系统性血管炎表现(如肺泡出血和肾小球肾炎),尤其在GPA或EGPA、胞质型/抗PR3 ANCA阳性或ANCA阴性患者中(风险比均>1.9),但MPA或核周型/抗髓过氧化物酶ANCA患者中未见此关联。
关键数值与推荐
- GPA皮肤表现比例34%,MPA 28%,EGPA 47%。
- 瘀点/紫癜见于15%的AAV患者。
- EGPA中瘙痒、荨麻疹和斑丘疹较其他亚型更常见(P < 0.01)。
- 皮肤活检诊断AAV的效力为68–94%。
- GPA、EGPA、胞质型/抗PR3 ANCA阳性或ANCA阴性伴皮肤病变者严重系统表现风险比>1.9。
临床怎么用
- 在AAV评估中应重视皮肤检查,皮肤表现常见且多样。
- 对疑似AAV患者,皮肤活检虽使用不足但诊断效力高,可考虑用于诊断。
- GPA、EGPA、胞质型/抗PR3 ANCA阳性或ANCA阴性患者出现皮肤病变时,需警惕严重系统性血管炎表现。
局限性
- 横断面设计无法确定因果关系。
- 皮肤活检执行率较低(22–44%),可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Cutaneous manifestations of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), including granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), and eosinophilic granulomatosis with polyangiitis (EGPA), are poorly characterized. This report describes the dermatologic features of AAV and their association with systemic manifestations of vasculitis. METHODS: A cross-sectional study identifying and comparing the cutaneous manifestations of AAV was performed using data from a large, international, collaborative effort in order to collect comprehensive clinical data on patients with vasculitis. RESULTS: Data from 1,184 patients with AAV from 130 centers worldwide were available. Cutaneous manifestations were common in all AAV subtypes: GPA (223 of 656, or 34%), MPA (85 of 302, or 28%), and EGPA (106 of 226, or 47%). The most frequent cutaneous manifestation in AAV (all types) was petechiae/purpura, which was observed in 181 patients (15%). Allergic and nonspecific manifestations, such as pruritus, urticaria, and maculopapular rash, were more common in EGPA than in other disease subtypes (all P < 0.01). Skin biopsy, while underutilized (performed in 22-44% of patients), was frequently found to be an effective test suitable for diagnosis of AAV (diagnostic in 68-94% of patients). Compared to patients without cutaneous manifestations, those with skin lesions more frequently had severe systemic manifestations of vasculitis (such as alveolar hemorrhage and glomerulonephritis), specifically patients with GPA or EGPA and cytoplasmic/anti-proteinase 3 (anti-PR3) ANCA-positive or ANCA-negative patients (hazard ratio >1.9 for all), but not those with MPA or perinuclear/antimyeloperoxidase ANCAs. CONCLUSION: Cutaneous manifestations are common and varied in AAV and are associated with disease severity in patients with GPA, EGPA, cytoplasmic/anti-PR3 ANCA, or ANCA-negative disease. These findings underscore the potential diagnostic and prognostic importance of the cutaneous examination in the evaluation and management of AAV.
引用
- Micheletti RG, Chiesa Fuxench Z, Craven A, et al. Cutaneous Manifestations of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Arthritis Rheumatol. 2020. PMID: 32419292. doi:10.1002/art.41310
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。